IRCT20091108002680N3尚未招募3 期
Assessment of the effect of nano-curcumin oral intake on clinical signs and serum IL-6 levels in patients with ischemic stroke: Double-blind Clinical Trial
Rasht University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Ischemic CVA less than 1 week from their symptoms begin
- •National Institutes of Health Stroke Scale (NIHSS) <= 20
- •Modified Rankin Scale (MRS) <= 4
排除标准
- •Cerebral Venous Thrombosis
- •Hemorrhagic infarction
- •Internal capsule and Middle Cerebral Artery trunk infarction
- •History of gall bladder stone or bile duct stenosis
- •Gastroesophageal reflux disease or active peptic ulcer
- •Use of NSAIDs or Reserpine
- •Using anticoagulant or thrombolitic agent in last 24 hours
- •Using of Warfarin in last 1 week
- •Dissatisfaction
- •More than 1 week from symptoms begin
研究者
相似试验
已完成
2 期
Observing the effect of nanocurcumin oral product in preventing cisplatin nephrotoxicity in cancer patientsCancer.IRCT20200408046990N11Mashhad University of Medical Sciences40
招募中
2 期
Evaluation of oral nano-formulation of Curcumin efficacy, as an adjuvant to XELOX or FOLFOX regimen treatment for metastatic colorectal cancer: A triple blinded, randomized clinical trialMetastatic colorectal cancer.Secondary malignant neoplasm of large intestine and rectumC78.5IRCT20200408046990N7Mashhad University of Medical Sciences60
已完成
不适用
Effect of oral nanocurcumin in patients with Behcet's disease.Behcet's diseaseBehcet's disease.M35.2IRCT20160422027520N12Connective Tissue Diseases Research Center36
已完成
不适用
Effect of Nano-curcumin in Coronary Slow Flow PhenomenoIRCT20131125015536N8Tehran University of Medical Sciences42
招募中
2 期
Assessing the effect of nanomisel curcumin on prevention and treatment of nanomisel curcumiOral Candidiasis.Candidal stomatitis/Oral thrushB 37.0IRCT20180416039318N3Mashhad University of Medical Sciences40